Mohammed Nadershah

Dr. Mohammed Nadershah

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2019 in Journal of Maxillofacial and Oral Surgery
Verified
Journal Article
Closed access
PDF file
MNMohammed Nadershah
Mohammed Nadershah
HAHala M. Abdel-Alim
Hala M. Abdel-Alim
ABAmr M. Bayoumi
Amr M. Bayoumi
AJAhmed M. Jan
Ahmed M. Jan
AEAli Elatrouni
Ali Elatrouni
FJFatima M. Jadu
Fatima M. Jadu

1 May 2012 in Oral and Maxillofacial Surgery Clinics of North America
Verified
Journal Article
Closed access
MNMohammed Nadershah
Mohammed Nadershah
ASAndrew Salama
Andrew Salama

13 December 2014 in The Saudi Dental Journal
Verified
Journal Article
Open access
AAAhmad Alshadwi
Ahmad Alshadwi
MNMohammed Nadershah
Mohammed Nadershah
TOTimothy Osborn
Timothy Osborn
Objective: The aim of this article is to review the mechanism of action, physiological effects, and therapeutic applications of botulinum neurotoxins in the head and neck area. Study design: An extensive literature search was performed using keywords. The resulting articles were analyzed for relevance in four areas: overview on botulinum neurotoxins, the role of botulinum neurotoxins in the management of salivary secretory disorders, the role of botulinum neurotoxins in the management of facial pain, and the role of botulinum neurotoxins in head and neck movement disorders. Institutional review board approval was not needed due the nature of the study. Results: Botulinum neurotoxin therapy was demonstrated to be a valuable alternative to conventional medical therapy for many conditions affecting the head and neck area in terms of morbidly, mortality, and patient satisfaction with treatment outcomes. Conclusion: Botulinum neurotoxin therapy provides viable alternatives to traditional treatment modalities for some conditions affecting the head and neck region that have neurological components. This therapy can overcome some of the morbidities associated with conventional therapy. More research is needed to determine the ideal doses of botulinum neurotoxin to treat different diseases affecting the head and neck regions.

18 October 2012 in Case Reports in Dentistry
Verified
Journal Article
Open access
PDF file
MNMohammed Nadershah
Mohammed Nadershah
AAAhmad Alshadwi
Ahmad Alshadwi
ASAndrew Salama
Andrew Salama
Pilomatrixoma, also known as pilomatricoma, is a benign tumor that originates from the matrix of the hair root. It usually presents as a single, slow-growing subcutaneous or intradermal firm nodule with a general size of less than 3 centimeters (cm) in diameter. However, giant pilomatrixomas (more than 5 cm) have been reported infrequently. It is more common in females and usually presents during the first two decades of life (60%) as an asymptomatic, mobile, hard, elastic mass. Most of the cases are benign and affect the face. The authors report a rare case of a giant pilomatricoma of the cheek and discuss the surgical management of these lesions, histopathological findings, and review of the literature.


1 February 2013 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
MNMohammed Nadershah
Mohammed Nadershah
AAAhmed Alshadwi
Ahmed Alshadwi
ASAndrew Salama
Andrew Salama